Related Experiment Video
Updated: Jun 25, 2026

A Guide to Production, Crystallization, and Structure Determination of Human IKK1/α
Published on: November 2, 2018
An F-box protein, FBXW5, negatively regulates TAK1 MAP3K in the IL-1beta signaling pathway
Yasumasa Minoda1, Hiroaki Sakurai, Takashi Kobayashi
1Division of Molecular and Cellular Immunology, Medical Institute of Bioregulation, Kyushu University, Fukuoka 812-8582, Japan.
Abstract:
TAK1, a member of the MAP3K family, plays an essential role in activation of JNK/p38 MAPKs and IKK in the IL-1beta and TNFalpha signaling pathway. Upon stimulation, TAK1 is rapidly and transiently activated. While the activation mechanism of TAK1 in these signaling pathways is well characterized, how its activity is terminated still remains unclear. To identify the molecule(s) involved in TAK1 regulation, we performed tandem affinity purification (TAP) in HeLa cells stably expressing TAP-tagged TAK1. FBXW5, an F-box family protein, was identified as a previously unknown component of the IL-1beta-induced TAK1 complex. FBXW5 associated with endogenous TAK1 in an IL-1beta-dependent manner. Overexpression of FBXW5 inhibited IL-1beta-induced activation of JNK/p38 MAPKs and NF-kappaB as well as phosphorylation of TAK1 on Thr187. Conversely, knockdown of FBXW5 resulted in the prolonged activation of TAK1 upon IL-1beta stimulation. These results suggest that FBXW5 negatively regulates TAK1 in the IL-1beta signaling pathway.
Insights
FBXW5 is a newly discovered protein that regulates TAK1 activity in the IL-1beta signaling pathway. This finding clarifies how TAK1 activation is terminated, offering new insights into inflammatory responses.
Area of Science:
- Cellular signaling pathways
- Molecular biology
- Immunology
Background:
- Transforming growth factor-beta-activated kinase 1 (TAK1) is crucial for activating JNK/p38 MAPKs and IKK in IL-1beta and TNFalpha signaling.
- TAK1 activation is rapid and transient, but the mechanisms for its termination remain largely unknown.
Purpose of the Study:
- To identify molecules involved in the negative regulation of TAK1 activity.
- To elucidate the role of novel regulatory factors in the IL-1beta signaling pathway.
Main Methods:
- Tandem affinity purification (TAP) in HeLa cells stably expressing TAP-tagged TAK1.
- Co-immunoprecipitation assays to assess protein interactions.
- Western blotting to evaluate protein phosphorylation and signaling pathway activation.
Main Results:
- FBXW5, an F-box protein, was identified as a novel component of the IL-1beta-induced TAK1 complex.
- FBXW5 binds to TAK1 in an IL-1beta-dependent manner.
- Overexpression of FBXW5 inhibited IL-1beta-induced JNK/p38 MAPKs and NF-kappaB activation, and TAK1 phosphorylation.
- FBXW5 knockdown led to prolonged TAK1 activation following IL-1beta stimulation.
Conclusions:
- FBXW5 negatively regulates TAK1 activity within the IL-1beta signaling pathway.
- FBXW5 plays a critical role in terminating TAK1 activation, thereby controlling inflammatory responses.
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
TGF - β Signaling Pathway
MAPK Signaling Cascades
The JAK-STAT Signaling Pathway
NF-kB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
PI3K/mTOR/AKT Signaling Pathway
